Published in Lab Business Week, April 20th, 2008
"Specifically, some agonists selectively activate cellular pathways, demonstrate phenotypic...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.